INTEGRATED DNA TECHNOLOGIES INC.

Company Snapshot

Founded: 1987

Entity Type: Private

Region: U.S.

Headquarter: U.S.

Key Geographics: North America, Europe, Asia-Pacific

Corporate Address: 1710 Commercial Park Coralville, Iowa 52241 U.S. Tel. +1-800-328-2661 www.sg.idtdna.com

Company Overview

Integrated DNA Technologies, Inc. (IDT) provides customized nucleic acids to the biotechnology, pharmaceutical, academic, and clinical diagnostics industries. Integrated DNA Technologies, Inc. was founded in 1987 through a collaboration between the University of Iowa Technology Innovation Centre and Baxter Healthcare Corporation. Custom RNA and DNA oligonucleotides (oligos) for research purposes is IDT's main line of business. From being a top provider of oligos, IDT has developed into a company that supports important fields like PCR, CRISPR, synthetic biology, and next-generation sequencing, giving researchers innovative tools and solutions. The company employs more than 2,000 people globally, serving customers in more than 100 countries. IDT is a part of Danaher Corporation.

INTEGRATED DNA TECHNOLOGIES INC. In Reports

RNA Sequencing: Technologies and Global Markets

BCC Research Market Analyst says global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a CAGR of 19.1%.

Oligonucleotides: Global Markets

BCC Research Market Analyst says global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028 at a CAGR of 11.0%.

Global Next-Generation Sequencing on Drug Development Market

BCC Research Market Report says global next-generation sequencing market in drug development should reach $2.9 billion by 2028 from $1.3 billion in 2023 at a CAGR of 17.7%.

View All Reports

INTEGRATED DNA TECHNOLOGIES INC. In News

CRISPR Technology Market Set to Reach USD 14.75 Billion by 2032, Driven by Expanding Applications in Gene Editing, Drug Discovery, and Agriculture – SNS Insider - SINA HONG KONG LIMITED

SINA HONG KONG LIMITED - Jun 11, 2025

Company's Business Segments

Oligo & Genomics Solutions : The company provides Oligonucleotides and genomics solutions across multiple vital areas such as next-generation sequencing, CRISPR, synthetic biology, and PCR with the right tools as required.

Applications/End User Industries

Healthcare
Genomics

Biotechnology
CRISPR

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.